Medicine guide
NIPENT
As listed in the register: NIPENT 10 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION
10 mg · polvo para solución inyectable y para perfusión
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Pentostatina
- Made by
- Pfizer S.L.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicinesL01XX08
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Pfizer S.L. |
|---|---|
| Active substance | Pentostatina |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 10 mg |
| Form | polvo para solución inyectable y para perfusión |
| Classification | L01XX08 · Cancer treatments and immune-system medicines |
| Route | vía intravenosa |
| Marketed | Yes, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | NIPENT 10 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION |
| Nº Registro | 59993 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.